17D yellow fever vaccine elicits comparable long‑term immune responses in healthy individuals and immune‑compromised patients

Authored by: Wieten R. W., Goorhuis A., Jonker E. F. F., de Bree G. J., de Visser A. W., van Genderen P. J. J., Remmerswaal E. B. M., ten Berge I. J. M., Visser L. G., Grobusch M. P., van Leeuwen E. M. M.
In: JOURNAL OF INFECTION [aheadofprint], 2016, p.‑.
http://www.ncbi.nlm.nih.gov/pubmed/27017899